| Net Sales | 12.48B |
| Cost of sales | 9.84B |
| Research and development expenses | 399M |
| Selling, general and administrative expenses | 864M |
| Amortization of intangibles | 162M |
| Restructuring charges | 0 |
| Acquisition and integration related expenses | |
| Equity in earnings of nonconsolidated affiliates | 70M |
| Sundry income (expense) - net | -4M |
| Interest income | 26M |
| Interest expense and amortization of debt discount | |
| Income Before Income Taxes | 1.09B |
| Provision for income taxes | 271M |
| Net Income | 818M |
| Net income attributable to noncontrolling interests | 14M |
| Net Income attributable to The Dow Chemical Company | 804M |
| Preferred stock dividends | 85M |
| Net Income Available for The Dow Chemical Company Common Stockholders | 719M |
| Earnings per common share - basic | 0.64 |
| Earnings per common share - diluted | 0.63 |
| Common stock dividends declared per share of common stock | 0.46 |
| Weighted-average common shares outstanding - basic | 1.11B |
| Weighted-average common shares outstanding - diluted | 1.13B |
| Depreciation | 573M |
| Capital Expenditures | |